Specifically, PAK2 expression exhibited negative correlations across multiple critical steps of the cancer immune cycle, including the release of cancer antigens, antigen presentation, and the infiltration of immune cells into the tumor microenvironment. This evidence concerns the gene PAK2 and cancer.